|
Molecular methods for the diagnosis of cancer 1 Oncor, Inc. provided research funding for the study described in this paper. Under an agreement between Oncor and the Johns Hopkins University, Dr. Sidransky is entitled to a share of sales royalty received by the University from Oncor. Under that agreement, the University and Dr. Sidransky also have received Oncor stock which, under University policy, cannot be traded until two years after the first commercial sales of the products related to this research. The terms of this arrangement have been reviewed and approved by the University in accordance with its conflict of interest policies. 1 |
|
|